-
1
-
-
33847377956
-
Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues
-
Cornaglia G, Akova M, Amicosante G et al. Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int J Antimicrob Agents 2007; 29: 380-8.
-
(2007)
Int J Antimicrob Agents
, vol.29
, pp. 380-388
-
-
Cornaglia, G.1
Akova, M.2
Amicosante, G.3
-
2
-
-
40749134174
-
Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek university hospital
-
Souli M, Kontopidou FV, Papadomichelakis E et al. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek university hospital. Clin Infect Dis 2008; 46: 847-54.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 847-854
-
-
Souli, M.1
Kontopidou, F.V.2
Papadomichelakis, E.3
-
3
-
-
66149110334
-
Prospective observational study of the impact of VIM-1 metallo-β-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections
-
Daikos GL, Petrikkos P, Psichogiou M et al. Prospective observational study of the impact of VIM-1 metallo-β-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 2009; 53: 1868-73.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 1868-1873
-
-
Daikos, G.L.1
Petrikkos, P.2
Psichogiou, M.3
-
4
-
-
74549182171
-
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
-
Miriagou V, Cornaglia G, Edelstein M et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 2010; 16: 112-22.
-
(2010)
Clin Microbiol Infect
, vol.16
, pp. 112-122
-
-
Miriagou, V.1
Cornaglia, G.2
Edelstein, M.3
-
6
-
-
74549155155
-
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
-
Carmeli Y, Akova M, Cornaglia G et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010; 16: 102-11.
-
(2010)
Clin Microbiol Infect
, vol.16
, pp. 102-111
-
-
Carmeli, Y.1
Akova, M.2
Cornaglia, G.3
-
8
-
-
0035262126
-
Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species
-
Lee K, Chong Y, Shin HB et al. Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2000; 7: 88-91.
-
(2000)
Clin Microbiol Infect
, vol.7
, pp. 88-91
-
-
Lee, K.1
Chong, Y.2
Shin, H.B.3
-
9
-
-
0034023159
-
Characterization of VIM-2, a carbapenemhydrolysing metallo-β-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France
-
Poirel L, Naas T, Nicolas D et al. Characterization of VIM-2, a carbapenemhydrolysing metallo-β-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2000; 44: 891-7.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 891-897
-
-
Poirel, L.1
Naas, T.2
Nicolas, D.3
-
10
-
-
4243894113
-
Assay of antimicrobials
-
Lennette EH, Balows A, Hausler Jr et al., eds. Washington, DC: American Society for Microbiology
-
Sabath LD, Anhalt JP. Assay of antimicrobials. In: Lennette EH, Balows A, Hausler Jr et al., eds. Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology, 1980; 485-90.
-
(1980)
Manual of Clinical Microbiology
, pp. 485-490
-
-
Sabath, L.D.1
Anhalt, J.P.2
-
11
-
-
44949156232
-
Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis
-
Tsaganos T, Kouki P, Digenis P et al. Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis. Int J Infect Dis 2008; 32: 46-9.
-
(2008)
Int J Infect Dis
, vol.32
, pp. 46-49
-
-
Tsaganos, T.1
Kouki, P.2
Digenis, P.3
-
12
-
-
0344146475
-
Activities of the oxazolidinones linezolid and eperezolid in experimental inta-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium
-
Schulin T, Thauvin-Eliopoulos C, Moellering RC et al. Activities of the oxazolidinones linezolid and eperezolid in experimental inta-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 1999; 43: 2873-6.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 2873-2876
-
-
Schulin, T.1
Thauvin-Eliopoulos, C.2
Moellering, R.C.3
-
13
-
-
35948970570
-
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial
-
Sakka SG, Glauner AK, Bulitta JB et al. Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial. Antimicrob Agents Chemother 2007; 51: 3304-10.
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 3304-3310
-
-
Sakka, S.G.1
Glauner, A.K.2
Bulitta, J.B.3
-
14
-
-
0345130000
-
Continuous infusion versus intermittent administration of meropenem in critically ill patients
-
Thalhammer F, Traunmüller F, El Menyawi I et al. Continuous infusion versus intermittent administration of meropenem in critically ill patients. J Antimicrob Chemother 1999; 43: 523-7.
-
(1999)
J Antimicrob Chemother
, vol.43
, pp. 523-527
-
-
Thalhammer, F.1
Traunmüller, F.2
El Menyawi, I.3
-
15
-
-
3042637085
-
Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians
-
Nix DE, Majumdar AK, DiNubile MJ. Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians. J Antimicrob Chemother 2004; 53 Suppl 2: ii23-8.
-
(2004)
J Antimicrob Chemother
, vol.53
, Issue.SUPPL. 2
-
-
Nix, D.E.1
Majumdar, A.K.2
DiNubile, M.J.3
-
16
-
-
35948951943
-
Parmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using Monte Carlo simulation
-
Vinks AA, van Rossem RN, Mathôt RAA et al. Parmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using Monte Carlo simulation. Antimicrob Agents Chemother 2007; 51: 3049-55.
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 3049-3055
-
-
Vinks, A.A.1
van Rossem, R.N.2
Mathôt, R.A.A.3
-
17
-
-
44449116776
-
High rates of metallo-β-lactamase-producing Klebsiella pneumoniae in Greece - a review of the current evidence
-
pii=8023
-
Vatopoulos A. High rates of metallo-β-lactamase-producing Klebsiella pneumoniae in Greece - a review of the current evidence. Euro Surveill 2008; 13: pii=8023.
-
(2008)
Euro Surveill
, pp. 13
-
-
Vatopoulos, A.1
-
18
-
-
0036751668
-
Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in Greece
-
Galani I, Xirouchaki E, Kanellakopoulou K et al. Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in Greece. Clin Microbiol Infect 2002; 8: 579-88.
-
(2002)
Clin Microbiol Infect
, vol.8
, pp. 579-588
-
-
Galani, I.1
Xirouchaki, E.2
Kanellakopoulou, K.3
-
19
-
-
0037439449
-
Prevention of resistance: a goal for dose selection for antimicrobial agents
-
Drusano GL. Prevention of resistance: a goal for dose selection for antimicrobial agents. Clin Infect Dis 2000; 36 Suppl 2: 42-50.
-
(2000)
Clin Infect Dis
, vol.36
, Issue.SUPPL. 2
, pp. 42-50
-
-
Drusano, G.L.1
-
20
-
-
33846296202
-
Activity of imipenem against VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model
-
Daikos GL, Panagiotakopoulou A, Tzelepi E et al. Activity of imipenem against VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model. Clin Microbiol Infect 2007; 13: 202-5.
-
(2007)
Clin Microbiol Infect
, vol.13
, pp. 202-205
-
-
Daikos, G.L.1
Panagiotakopoulou, A.2
Tzelepi, E.3
-
21
-
-
34248210168
-
Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-β-lactamase VIM-1 in Greece
-
Galani I, Souli M, Koratzanis E et al. Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-β-lactamase VIM-1 in Greece. J Antimicrob Chemother 2007; 59: 578-9.
-
(2007)
J Antimicrob Chemother
, vol.59
, pp. 578-579
-
-
Galani, I.1
Souli, M.2
Koratzanis, E.3
-
22
-
-
18844420212
-
VIM-1 and aac(6′)-IIc in an Enterobacter cloacae clinical isolate from Greece
-
VIM-1 and aac(6′)-IIc in an Enterobacter cloacae clinical isolate from Greece. J Antimicrob Chemother 2005; 55: 634-8.
-
(2005)
J Antimicrob Chemother
, vol.55
, pp. 634-638
-
-
Galani, I.1
Souli, M.2
Chryssouli, Z.3
|